Home »
Thailand’s prime minister said he wants to secure more vaccines for his country and give as many first doses as possible, as it battles a surge of the pandemic with Bangkok reporting a record number
EU chief Charles Michel said the bloc is ready to discuss a US proposal to lift patents on COVID-19 vaccines once the details are clear. “We are ready to engage on this topic, as soon
After navigating a pandemic that turned the world – including the world of hospital medicine – upside down for so long, the very idea of returning to a “normal” career and way of life can
CHICAGO (Reuters) – Novavax Inc’s COVID-19 vaccine had efficacy of 51% against infections caused by the South African variant among people who were HIV negative, and 43% in a group that included people who were
Vaccines are being rolled out in many countries to contain the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the coronavirus disease 2019 (COVID-19). However, immune-evading mutations have been observed
High consumption of sugar-sweetened beverages (SSB) in adolescence and young adulthood could partially explain the recent rapid rise in early-onset colorectal cancer (EO-CRC) — at least in women, according to the authors of a new
Dr Siegel calls out ‘antiquated’ CDC guidance on mask-wearing for children Fox News contributor Dr. Marc Siegel says recent strict guidance from the CDC for summer camps is ‘not following the science.’ British Prime Minister
Pfizer and partner BioNTech announced they are starting the process to seek full Food and Drug Administration approval in the U.S. for their COVID-19 vaccine. Since December, their vaccine has been distributed in the U.S.
A bold US bid to waive patents on much-needed coronavirus vaccines was strongly opposed by Germany on Thursday, threatening to derail the proposal that requires the consensus of World Trade Organization members to pass. Pfizer
The World Health Organization on Thursday warned of a new wave of COVID-19 infections in Africa due to delayed vaccine supplies, a slow rollout and new variants. The African bureau of the UN agency said